No. of Pages: 168 | Report Code: TIPRE00024510 | Category: Life Sciences
细胞治疗生物加工是生物加工工程的一个子领域，它将细胞治疗和生物加工（即生物制药制造）联系起来。细胞治疗是生命科学中发展最快的领域之一。它需要将整个活细胞输送给患者来治疗疾病。
因此，细胞疗法的批准不断增加，预计将在未来几年对细胞疗法生物加工产生巨大需求，预计这将进一步推动细胞治疗生物加工市场。
正如《自然新闻》最近的一篇文章所总结的那样，由于多种原因，COVID-19 的全球分布干扰了已建立的临床试验。与此同时，这场大流行使私人和公众大规模动员起来，以促进新的诊断、预防性疫苗接种和治疗。细胞和基因治疗制造商参与了这次动员的各个方面。据 ClinicalTrials.gov 称，大约 70 项正在进行的预防或治疗 COVID-19 的细胞和基因疗法研究于 2020 年 5 月 12 日开始。具有抗炎途径的细胞疗法产品似乎非常适合 COVID-19 疗法也正在接受调查。细胞和基因疗法的生产可能需要使用各种人类和动物生物材料。必须解释源自人血浆和血液的产品会受到污染的风险，但对用于 SARS-CoV-2 的捐献者和捐献材料进行自愿筛查和检测可能是一项谨慎的措施。制造阶段（开放与封闭）：对于早期研究，这些产品仍然是在不太封闭或开放封闭的平台中生产的，使用经常位于非 cGMP 环境中的环保生物防护柜，尽管目前的趋势是移动从使用开放式生产平台到封闭式系统。这种较低的控制水平增加了 SARS-CoV-2 操作者污染产品的风险。所有这些方面都将增加北美地区细胞治疗生物加工市场的未来需求。
< strong>市场概况和动态
北美细胞治疗生物加工市场预计将从 2021 年的 55.919 亿美元增长到 2028 年的 137.010 亿美元;预计 2021 年至 2028 年复合年增长率为 13.7%。自动化程序还将有助于扩大产量并以最少的跟踪连续生产不同批次。它还将通过实现制造能力的快速扩展来提高生产率。有几个公司开发自动化流程的例子。 2020 年 7 月，赛默飞世尔科技 (Thermo Fisher Scientific Inc.) 和 Lyell Nutrition 建立合作伙伴关系，共同开发和制造工艺，为癌症患者设计有效的细胞疗法。根据这一合作伙伴关系，两家公司的目标是提高 T 细胞的适应性，并支持开发符合 cGMP 的集成平台（系统和软件）以及试剂、耗材和仪器。同样，2019 年 3 月，Lonza 与以色列 Sheba 医疗中心建立合作伙伴关系，利用其护理点 Cocoon 细胞疗法制造平台提供自动化和封闭式 CAR-T 制造。因此，采用自动化程序将有助于克服与细胞治疗生物加工相关的挑战，并为市场参与者提供增长机会，这将有助于未来几年的市场增长。
从技术角度来看，生物反应器细分市场在2020年北美细胞治疗生物加工市场中占据最大份额就细胞类型而言，干细胞细分市场占据2020年北美细胞治疗生物加工市场最大份额；就适应症而言，肿瘤细分市场占据2020年北美细胞治疗生物加工市场最大份额. 从最终用户来看，学术和研究机构细分市场在2020年细胞治疗生物加工市场中占有较大的市场份额。
准备本细胞疗法报告时参考的一些主要一手和二手来源北美的生物加工市场包括公司网站、年度报告、财务报告、国家政府文件和统计数据库等。报告中列出的主要公司包括 Fresenius Kabi Ag.、Asahi Kasei Corporation、Sartorius Ag、Merck Kgaa、Thermo Fisher Scientific Inc.、Corning Incorporated、Cytiva (Ge Healthcare)、Lonza、Repligen 和 Catalent Inc.
< p>作者技术
;
按细胞类型
按适应症
最终用户
按国家划分
Strategic insights for North America Cell Therapy Bioprocessing involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 5,591.9 Million |
| Market Size by 2028 | US$ 13,701.0 Million |
| Global CAGR (2021 - 2028) | 13.7% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By 技术
|
| Regions and Countries Covered | 北美
|
| Market leaders and key company profiles |
The regional scope of North America Cell Therapy Bioprocessing refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The North America Cell Therapy Bioprocessing Market is valued at US$ 5,591.9 Million in 2021, it is projected to reach US$ 13,701.0 Million by 2028.
As per our report North America Cell Therapy Bioprocessing Market, the market size is valued at US$ 5,591.9 Million in 2021, projecting it to reach US$ 13,701.0 Million by 2028. This translates to a CAGR of approximately 13.7% during the forecast period.
The North America Cell Therapy Bioprocessing Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Cell Therapy Bioprocessing Market report:
The North America Cell Therapy Bioprocessing Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Cell Therapy Bioprocessing Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Cell Therapy Bioprocessing Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America Cell Therapy Bioprocessing Market
